Investor Presentaiton

Quarterly Performance Net Revenue from Operations (IN MILLION) 3491.79 3514.06 3534.35 III (IN MILLION & %) EBITDA (incl. Other Rev) and EBITDA Margin PAT and PAT Margin 565.78 16.20% Q2FY21 Q1FY22 Q2FY22 ■Revenue from Operations Q2FY21 heranba.co.in EBITDA 19.66% 663.5 18.77% (IN MILLION & %) 456.15 12.91% Business Mix (IN %) 10.11% 8.89% 30.08% 32.07% 25.66% 23.19% 690.91 377.28 473.87 Q1FY22 Q2FY22 Q2FY21 Q1FY22 Q2FY22 32.16% Q2FY21 37.83% Q2FY22 -EBITDA Margin PAT -PAT Margin Export Formulations Export Technicals Domestic Formulations Domestic Technicals NOTE: Domestic Formulations includes Branded Formulations and Public Health 16

View entire presentation